
TherapeuticsMD (NASDAQ:TXMD) brought in sales totaling $19.33 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 14.11%, resulting in a loss of $49.02 million. TherapeuticsMD collected $18.68 million in revenue during Q4, but reported earnings showed a $42.96 million loss.